Medicines NZ

The weight-loss drug Wegovy (semaglutide), manufactured by the Danish company Novo Nordisk, received approval on 20 March and the company confirms it is exploring options to make the drug available locally as soon as possible, but has no time frame for this.

Unused medicines are being put to good use overseas thanks to the hard work of volunteers, reports Jody Hopkinson

Medsafe group manager Chris James explains how the process for classifying medicines works in New Zealand

Pseudoephedrine-based cold and flu medications can now be purchased from pharmacists

The new Government began the process of repealing the Therapeutic Products Act last month, but pharmaceutical sector leaders say they are still in the dark about what will replace it.

Associate health minister Casey Costello is seeking approval from Cabinet to repeal the Therapeutic Products Act this week 

The delisting date for cilazapril has been pushed out to mid2024, Pharmac reports.

Medicines New Zealand says political parties’ pre-election pledges to increase Pharmac’s funding are positive, but much more will be needed if the next government wants to clear the backlog of unfunded medicines

The publication of drug companies’ payments to doctors is a boon for transparency and for patients’ understanding of the relationship between the industry and their healthcare professional, says Medicines New Zealand

After a four-year hiatus, Medicines New Zealand has relaunched its annual Value of Medicines award, this time adding a new award for young scientists worth $30,000